Get the Stockscreener App
1.37
0.00%
0.00
Lifeward Ltd stock is traded at $1.37, with a volume of 107.86K.
It is up +0.00% in the last 24 hours and down -4.20% over the past month.
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
See More
Previous Close:
$1.37
Open:
$1.37
24h Volume:
107.86K
Relative Volume:
0.05
Market Cap:
$14.99M
Revenue:
$23.28M
Net Income/Loss:
$-23.75M
P/E Ratio:
-0.4492
EPS:
-3.05
Net Cash Flow:
$-25.22M
1W Performance:
-2.84%
1M Performance:
-4.20%
6M Performance:
-37.73%
1Y Performance:
-73.45%
1-Day Range:
$1.36
$1.3887
1-Week Range:
$1.3004
$1.41
52-Week Range:
$1.22
$5.25
Lifeward Ltd Stock (LFWD) Company Profile
Name
Lifeward Ltd
Sector
Industry
Phone
15082511154
Address
200 DONALD LYNCH BLVD., MARLBOROUGH
Compare LFWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
1.37 | 14.99M | 23.28M | -23.75M | -25.22M | -3.05 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-25 | Initiated | Laidlaw | Buy |
| Apr-03-17 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-16-16 | Initiated | Oppenheimer | Outperform |
| Jul-15-16 | Initiated | Piper Jaffray | Overweight |
| May-22-15 | Upgrade | Canaccord Genuity | Hold → Buy |
| May-08-15 | Reiterated | Barclays | Equal Weight |
| Oct-07-14 | Initiated | Barclays | Equal Weight |
View All
Lifeward Ltd Stock (LFWD) Latest News
Lifeward (LFWD) Advances Exoskeleton Technology with AI Integration | LFWD Stock News - GuruFocus
Lifeward Completes Research Program with Israeli - GlobeNewswire
Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons - marketscreener.com
Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025 | LFWD Stock News - GuruFocus
Lifeward Ltd. to Release First Quarter 2025 Financial Results on May 15, 2025 - Nasdaq
Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025 - GlobeNewswire
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Lifeward (LFWD) Secures Insurance Approval for ReWalk 7 Exoskele - GuruFocus
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton - GlobeNewswire
Major Insurance Breakthrough: ReWalk 7 Exoskeleton Gets Historic First Commercial Coverage - Stock Titan
Lifeward Ltd. Reports Third Quarter 2024 Financial Results - ADVFN
Israeli Soldier Becomes First War Casualty to Use ReWalk Exoskeleton (LFWD) | LFWD Stock News - GuruFocus
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Per - GuruFocus
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton - The Manila Times
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton | LFWD Stock News - GuruFocus
Revolutionary ReWalk Exoskeleton Helps Paralyzed Israeli Soldier Walk: Military Healthcare Breakthrough - Stock Titan
Lifeward launches sales of ReWalk 7 personal exoskeleton in U.S. - MSN
LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7 - MSN
Lifeward launches ReWalk 7 exoskeleton for spinal injury patients By Investing.com - Investing.com South Africa
Lifeward (LFWD) Launches ReWalk 7 Exoskeleton in the U.S., Shares Rise - GuruFocus
Lifeward (LFWD) Launches Next-Gen ReWalk 7 Personal Exoskeleton Nationwide | LFWD Stock News - GuruFocus
Lifeward launches ReWalk 7 exoskeleton for spinal injury patients - Investing.com Australia
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market | LFWD Stock News - GuruFocus
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market - The Manila Times
Lifeward Ltd. reports preliminary Q1 financial results - Investing.com Australia
Lifeward Ltd. reports preliminary Q1 financial results By Investing.com - Investing.com Canada
ReWalk Robotics stock hits 52-week low at $1.25 amid market challenges - Investing.com Australia
ReWalk Robotics stock hits 52-week low at $1.25 amid market challenges By Investing.com - Investing.com South Africa
Lifeward Ltd. (LFWD): Among the Penny Stocks With Huge Upside Potential According to Analysts - Insider Monkey
10 Penny Stocks With Huge Upside Potential According To Analysts - Insider Monkey
Lifeward Stock Falls Despite FDA Clearance of ReWalk 7 Exoskeleton - TradingView
Lifeward gains FDA clearance for new ReWalk exoskeleton - Investing.com
Sector Update: Health Care Stocks Softer Thursday Afternoon -March 13, 2025 at 02:06 pm EDT - Marketscreener.com
Sector Update: Health Care -March 13, 2025 at 01:43 pm EDT - Marketscreener.com
What's Going On With Lifeward Shares Thursday?Lifeward (NASDAQ:LFWD) - Benzinga
FDA Approval of ReWalk7 Sends Lifeward (LFWD) Stock Climbing - Stocks Telegraph
Lifeward announces FDA clearance for ReWalk 7 exoskeleton - TipRanks
Lifeward Receives FDA Clearance for ReWalk 7 Exoskeleton; Shares Jump -March 13, 2025 at 09:41 am EDT - Marketscreener.com
Lifeward gains FDA clearance for new ReWalk exoskeleton By Investing.com - Investing.com UK
FDA Issues Clearance for ReWalk 7 Exoskeleton - GlobeNewswire
Lifeward Ltd Stock (LFWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):